January 2019 | Volume 7, Issue 1
   Website      About      Faculty/Staff      News/Events      Projects/Programs
EVIDENCE IN ACTION
A quarterly research brief from the
Center on Trauma and Children

America's Opioid Crisis:   
Implications for Child Serving Professionals
A review of the article: 
Bushman, G., Victor, B.G., Ryan, J.P., Perron, B.E. (2018). In Utero Exposure to Opioids: An Observational Study of Mothers Involved in the Child Welfare System. Substance Use & Misuse, 53 (5), 844-851.

Opioid misuse has reached epidemic proportions in the United States. In addition to medical complications, overdose and death, opioids affect the developing fetus. A specific syndrome, Neonatal Opioid Withdrawal Syndrome (NOWS) describes the features of infants who are withdrawing from in utero exposure (IUE) to opioids. This syndrome involves multiple systems including (1) the central nervous system (high pitched cry, irritability, tremors, increased tone, seizures), (2) the gastrointestinal system (vomiting, poor feeding, uncoordinated sucking, loose stools, failure to thrive), and (3) autonomic dysfunction (sweating, sneezing, temperature instability, yawning, nasal stuffiness) (Sutter, Leeman, His, 2014). Long-term effects and the best ways to manage NOWS are unknown at present. Complicating matters, infants are often exposed to more than one substance. Because of this, the general term, Neonatal Abstinence Syndrome (NAS) is used.  
 
This study reviews 15 years of clinical assessment data from 3598 child welfare involved mothers to understand trends in IUE to opioids over time. The authors found a substantial increase in the rates of IUE to opioids in child-welfare involved mothers with the highest rate of opioid-related exposure among white mothers. Few African American mothers reported opioid-related exposures, but rates of exposure to marijuana were highest in this population. These findings raise important questions about how child welfare involved mothers are assessed and treated, particularly in regard to the IUE of their infants and children. It also highlights the possible importance of racial differences in populations most affected by the opioid epidemic.
 
Why Study Women Involved in Child Welfare?   
Women are at greater risk than men for opioid abuse since they are more likely to be prescribed opioids and to use them for longer periods of time (National Women's health Network, 2018). It has been shown that women involved in the child welfare system experience greater improvement when substance abuse treatment is integrated into their child welfare services. Studying this population could potentially lead to greater resources being directed at prevention and treatment of women and their children affected by opioid abuse. This is the first study that specifically examines IUE to opioids by the biological mothers of children in the child welfare system, helping workers and others who work with these individuals to better understand this population.
 
The Study
 
Design
(1)    The Juvenile Court Assessment program in Chicago and suburban Cook County provides drug and alcohol assessments to adults referred by the child welfare system. Record review identified that mothers aged 16 years and older screened between 1998 and 2013 comprised 51.5% of this group and included 3598 mothers.
(2)    At the time of intake, mothers were asked whether any of their children had been exposed to illicit substances during pregnancy. Women who endorsed substance exposure to illicit drugs (opioids, crack/cocaine, marijuana or other substances) provided detailed information regarding the specific substance to which each child was exposed and the age of each child. IUE to a substance was the primary outcome variable in this study.
(3)    Socio-demographic data obtained included race (identified as "white, black or other"), educational attainment, marital status, number of children, age, exposure year and employment status.
(4)    15 years of data were first analyzed to determine rates of opioid use during pregnancy over time. Rates of cocaine and marijuana use were also established so trends in opioid use could be compared. Rate estimates of prenatal exposure for each year and each substance were determined. Trends were also examined by 3 major race categories.
(5)    The sample was then restricted to IUEs from the most recent 5 year period from 2009-2013 so that findings would be reflective of current trends.
 
Limitations
(1)    This study was conducted utilizing data from a large urban county in the Midwest. These findings may not be generalizable to other regions and populations.
(2)    This study relies on self-report data in contrast to laboratory testing to confirm exposure. It is possible rates of exposure reported are underestimated or inaccurate.
(3)    Information regarding alcohol use or exposure was not obtained since alcohol is a legal substance.
(4)    Timing or amount of exposure to substances in utero is unknown as is the development of NAS or NOWS.
(5)    Race was identified as black, white or other, possibly missing other factors related to ethnicity if this had been asked about in more detail.
 
General Results
(1)    Between 1998 and 2013, 3598 mothers gave birth to 7659 children, 19% of whom were exposed to at least one substance and 15% exposed to more than one substance.
(2)    The most common exposure was to cocaine (69%) followed by heroin (20%), prescription opioids (11%) and marijuana (11%).
(3)    The majority of the children in this study were black (72%) with equal numbers being white (14%) or another race (14%).
(4)    The rate of IUE to prescription opioids has trended upward in all children from 1.6% in 1998 to 3.3% in 2013 (p = .004). The rate of IUE to prescription opioids rose dramatically more in white children (0% in 1998 to 14% in 2013, p < .001). This was followed by children not identified as black or white (0% in 1998 and 7% in 2013, p < .001). and black children where the numbers remained at 0% (p = .138).
(5)    IUE to heroin rose significantly in white children (1% in 1998 to 14% in 2013, p = 0.007) whereas it decreased significantly in black children (4% in 1998 to 3% in 2013, p = .004) and remained flat in children of another race. Combining these 3 groups led to little change in IUE to heroin for the group as a whole (p = .114).
(6)    The overall rate for IUE to crack/cocaine declined significantly over the study period (p = 0.002) with declines most notable in black children.
(7)    The overall rate of IUE to marijuana increased significantly between 1998 and 2013 (p < .001). Rates in black children increased from 1% in 1998 to 10% in 2013 (p < .001). This trend was similar for other races.
 
Results from Exposures 2009-2013
(1)    17% of mothers from the large group gave birth from 2009-2013. Their average age was 29 years and the average number of children was 3.6. Approximately 78% were never married, almost 50% had less than a high school education and almost 75% were unemployed.
(2)    About 23% of recent mothers reported at least one IUE to crack/cocaine (43%), marijuana (28%), prescription opioids (20%), or heroin (17%). Co-exposures to cocaine were most prevalent in mothers who reported an IUE to heroin (24%) but less so with prescription opioids (13%).
(3)    Of the 1232 infants born during this period, 18% were exposed to at least one substance, most commonly cocaine (42%), followed by marijuana (29%), prescription opioids (18%) and heroin (16%). Approximately 16% were exposed to more than one substance.
 
Implications for Practice
 
Preventing the deleterious effects of substance abuse in children and families is important for clinicians. This study is the first to document a substantial increase in IUE to opioids in mothers and children involved in the child welfare system over the past 15 years. These findings underscore the need for increased surveillance of mothers and children regarding substance use during pregnancy as well as throughout development and the need for targeted interventions.  
 
 
Practice Considerations
  1. Child serving professionals may be the first point of contact for opioid addicted women and have a particularly important role in detection and referral.
  2. The high rates of opioid as well as crack/cocaine and marijuana use in mothers in the child welfare system underscores the need for a comprehensive lifetime as well as current substance use history.
  3. If a positive substance history is obtained, mothers of childbearing age or who are already pregnant are particularly important targets of intervention.
  4. Medication-assisted treatment of opioid addiction during pregnancy and postpartum utilizing either methadone or buprenorphine is effective and results in improved outcomes for mother and fetus. Referral to a physician who specializes in this is indicated.
  5. Newborns, young infants and children born to mothers who have used substances should also be assessed and referred for medical or developmental evaluation as indicated.
  6. Clinicians should be alert to the shame and denial that may make reporting substance use difficult for some individuals. Opioid use may become a life-threatening issue with multiple medical risks. Coordination with or referral to a primary care physician, psychiatrist with addiction expertise and/or obstetrician/gynecologist is important. 
References

Klaman, S.L., Isaacs, K., Leopold, A., Perpich, J., Hayashi, S., Vender, J., Campopiano, M., Jones, H.E. (2017). Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance. J Addict Med, 11: 178-190.

 
Martin, C. E., Longinaker, N., & Terplan, M. (2015). Recent trends in treatment admissions for prescription opioid abuse during pregnancy. Journal of Substance Abuse Treatment, 48, 37-42.
 
National Women's Health Network (2018). Opioids and Women: From Prescription to Addiction. Retrieved from https://www.nwhn.org/prescription-addiction-opioid-epidemic/
 
Patrick, S.W., Davis, M.M., Lehmann, C.U., et al. (2015). Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol, 35:650-655.
 
Sutter, M.B., Leeman, L., Hsi, A. (2014). Neonatal Opioid Withdrawal Syndrome Obstet Gynecol Clin N Am, 41, 317-334 http://dx.doi.org/10.1016/j.ogc.2014.02.010
 
University of Kentucky Center on Trauma and Children
859-218-6901 | http://www.uky.edu/ctac
 


  Like us on Facebook   Follow us on Twitter   View our videos on YouTube   View our photos on flickr